IAN LINDSLEY, TONY MUSU and ADAM ROGALEWSKI 9th February 2023 There is more clarity about hazardous medicinal products but awareness still needs to be raised to protect workers. Health workers need protection at all stages of the lifecycle for hazardous… Read more
Prevention of occupational cancers in the health sector, EBN with ETUI unveil list of HMPs
Two and a half years ahead of the European Commission, the ETUI with the EBN has unveiled a list of 121 hazardous medicinal products (HMPs) commonly used in the healthcare sector that can cause cancer or reproductive disorders in professionals who… Read more
Mental and Psychosocial Health in Healthcare; Preventing Medication Errors and Adverse Events and Disorders in Healthcare Workers
Aims and Objectives Improving the mental and psychosocial health and wellbeing of healthcare workers by understanding the causes and effects and preventing mental and psychosocial health disorders and adverse events , mainly medication errors; and by implementing traceability systems and… Read more
Highlights of the outcome of CMD4 and the new provisions of the Carcinogens, Mutagens and Reprotoxins Directive
Inclusion of reprotoxic substances in the scope of the new Carcinogens, Mutagens and Reprotoxins Directive (CMRD). For 12 of these substances, a binding occupational maximum exposure level limit value will be introduced in Annex III of the Directive. Inclusion of… Read more
European Biosafety Network publishes new guidance to prevent sharps injuries
Healthcare workers and patients are being put at risk not only from COVID-19 but other deadly diseases as a result of an increase in sharps injuries entirely due to the pandemic. We must act now to stop this, not least… Read more
European Parliament approves legislation to stop cancer at work
Stop Cancer at Work Campaign calls on European Commission and European Council to include hazardous drugs and reprotoxins in legislation now The European Parliament has confirmed the need for immediate legislative action – not just guidance – to stop workers… Read more
European Cancer Organisation publishes new ‘Working Against Cancer’ report
Today the European Cancer Organisation published a consensus paper conveying the critical challenges for the cancer workforce in the context of implementing Europe’s Beating Cancer Plan. The report, ‘Working Against Cancer: Giving Professionals the Right Tools for the Job’,… Read more
Stop Cancer at Work Campaign calls on European Commission to get on with including hazardous drugs in legislation now
Inclusion of hazardous drugs in EU legislation supported by the European Parliament, majority of Member States and consensus of stakeholders and responses to independent report published by the European Commission today The Stop Cancer at Work Campaign believes that the… Read more
European Parliament votes to stop cancer at work and include hazardous drugs and reprotoxins in the Carcinogens and Mutagens Directive (CMD)
Stop Cancer at Work Campaign calls on the European Commission to work with the Parliament and Council to legislate now to prevent workplace cancer The European Parliament voted today to support the Stop Cancer at Work campaign’s demands for: Legislative… Read more
Preventing occupational exposure to cytotoxic drugs
Cytotoxic drugs (also referred to as cytostatic or antineoplastic drugs) describe a group of medicines designed to destroy cells that grow in a rapid and uncontrolled manner, preventing their replication or growth. Worldwide, these medicines are increasingly being used in… Read more
